|

Azacitidine (AZA) Clinical Trials

10 actively recruiting trials across 5 locations

Also known as: Azadine, Onureg, VIDAZA, Vidaza

Other5 trials

Gilteritinib in Combination With Venetoclax and Azacitidine for AML Patients With FLT3 Mutations Ineligible for Intensive Treatment
Phase 2
Study to Evaluate the Safety and Tolerability of EP0042
Phase 1/2
Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia
Phase 2
Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like Patients
Phase 2
Venetoclax-containing Therapy Combined With Microtransplant for Newly Diagnosed AML
Phase 2

Gilbert, Arizona1 trial

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Banner MD Anderson Cancer Center

Phase 3

Goodyear, Arizona1 trial

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Cancer Treatment Center of America Phoenix

Phase 3

Newport Beach, California1 trial

A Study of DSP-5336 in Relapsed/Refractory AML/ ALL With or Without MLL Rearrangement or NPM1 Mutation

Hoag Family Cancer Center

Phase 1/2

Boston, Massachusetts1 trial

A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax

Brigham and Women's Hospital

Phase 1/2

Basking Ridge, New Jersey1 trial

A Study of Azacitidine and Venetoclax Versus a Stem Cell Transplant in People 65 Years and Older With Acute Myeloid Leukemia

Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.